Scientific American spoke to the Michigan Senate candidate about how his background in medicine has shaped his outlook
With Luigi Mangione’s upcoming sentencing, John Oliver devotes the full episode to covering UnitedHealth Group: Why customers hate them, how they got so profitable, and why doctors are wishing explosive diarrhea on their board members.
My patient care has improved as conversations with the agent push my thinking beyond its usual limits. For the residents I supervise, however, the app’s speed and anticipatory helpfulness are a hindrance as much as an enhancement.
The vast majority of cases begin in the fallopian tubes — and removing them can reduce the risk by nearly 80 percent.
The new pills can lower cholesterol levels far below what can be achieved with statins, clinical trials have shown.
The oldest known cases, discovered among hunter-gatherers in Siberian graves, contradict the theory that the disease once was mild.
We devised a way to add a protective shield over anticancer immune cells, allowing them to enter cancer’s neighborhood unscathed and decapitate tumors.
Researchers are preparing to launch an unprecedented trial to protect people exposed to Ebola in the DRC and Uganda
The new strategy also holds promise for lung and colon tumors. Here’s how scientists discovered it.
A deep dive into multiple sclerosis — what causes it, how it’s diagnosed, and where treatment is headed
Spread the word